Archford Capital Strategies LLC Has $7.63 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Archford Capital Strategies LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 62.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,564 shares of the healthcare conglomerate's stock after acquiring an additional 5,625 shares during the period. UnitedHealth Group makes up approximately 1.1% of Archford Capital Strategies LLC's holdings, making the stock its 18th largest holding. Archford Capital Strategies LLC's holdings in UnitedHealth Group were worth $7,628,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the stock. Brighton Jones LLC grew its stake in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC lifted its holdings in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. Bank Pictet & Cie Europe AG lifted its holdings in UnitedHealth Group by 3.9% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after buying an additional 9,872 shares in the last quarter. Crestwood Advisors Group LLC lifted its holdings in UnitedHealth Group by 6.9% during the 4th quarter. Crestwood Advisors Group LLC now owns 4,147 shares of the healthcare conglomerate's stock worth $2,098,000 after buying an additional 269 shares in the last quarter. Finally, Impax Asset Management Group plc acquired a new position in UnitedHealth Group during the 4th quarter worth $700,000. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer now owns 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders acquired 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. HSBC reaffirmed a "reduce" rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Baird R W lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, June 11th. Morgan Stanley reduced their price target on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Royal Bank Of Canada reduced their price target on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Finally, Truist Financial restated a "buy" rating and issued a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $415.57.

UnitedHealth Group Stock Up 2.1%

Shares of UNH traded up $6.23 during midday trading on Friday, hitting $308.85. The stock had a trading volume of 13,584,804 shares, compared to its average volume of 7,465,895. The firm has a market cap of $280.17 billion, a price-to-earnings ratio of 12.93, a price-to-earnings-growth ratio of 1.43 and a beta of 0.44. The company has a 50 day simple moving average of $336.21 and a two-hundred day simple moving average of $454.51. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the business earned $6.91 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.